Health Catalyst
HCAT
187 hedge funds and large institutions have $2.19B invested in Health Catalyst in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 75 increasing their positions, 58 reducing their positions, and 34 closing their positions.
95% more call options, than puts
Call options by funds: $5M | Put options by funds: $2.56M
29% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 58
1.25% more ownership
Funds ownership: 104.8% → 106.04% (+1.2%)
6% less funds holding
Funds holding: 198 → 187 (-11)
18% less capital invested
Capital invested by funds: $2.67B → $2.19B (-$481M)
24% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$42.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$33.6M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$12.6M |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$11.5M |
| 5 |
Lazard Asset Management
New York
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$17.9M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$16.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.1M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$9.7M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$9.08M |
HCAT Hedge Fund Activity: Q4 2021 in Review
187 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q4 2021, worth a combined $2.19B — down 18% from $2.67B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of HCAT and 26 opened new positions — a net loss of 8 holders — while 58 trimmed existing stakes and 75 added.
The largest buyer was AllianceBernstein, adding an estimated $42.7M. The largest seller was Victory Capital Management, cutting an estimated $17.9M.
- 187 institutional investors held Health Catalyst (HCAT) as of Q4 2021, down from 198 in Q3 2021.
- Funds reported $2.19B of Health Catalyst stock for Q4 2021, down 18% quarter-over-quarter.
- 26 funds opened new Health Catalyst positions in Q4 2021 and 34 closed out, a net change of -8 holders.
- The largest Health Catalyst buyer in Q4 2021 was AllianceBernstein, an estimated $42.7M added.
- The largest Health Catalyst seller in Q4 2021 was Victory Capital Management, an estimated $17.9M sold.
Based on aggregated 13F filings for Q4 2021.